KeepAlong

GLP-1 titration schedule planner

For planning and record-keeping only — not medical advice. Your dose and schedule are set by your prescriber.

This planner turns an FDA label dose ladder into calendar dates. Pick your medication and your first-injection date; it lists each dose step with the earliest date the label's minimum interval allows. It never decides when to increase — that's your prescriber's call. It only does the date math.

KeepAlong — GLP-1 shot tracker & planning tools

The dates this planner produces are exactly what the KeepAlong app turns into injection-day reminders — with a home-screen widget counting down to your next shot.

The app is launching soon. The web tools on this site are free — no sign-up needed.

How the label dose ladders compare

All four injection ladders share one rule — a minimum of 4 weeks per step — but they differ in length and target. Sources: the FDA prescribing information for Wegovy, Ozempic, Mounjaro, and Zepbound (checked 2026-08-18).

ProductSteps (mg)Weeks to maintenanceMaintenance dose
Wegovy injection0.25 → 0.5 → 1 → 1.7 → 2.4162.4 mg recommended, or 1.7 mg
Ozempic injection0.25 → 0.5 → 1 → 24–120.5, 1, or 2 mg
Zepbound2.5 → 5 → 7.5 → 10 → 12.5 → 154–205, 10, or 15 mg (10 or 15 mg for OSA)
Mounjaro2.5 → 5 → 7.5 → 10 → 12.5 → 154–205–15 mg

Two things sit outside those ladders. Wegovy's label also carries a 7.2 mg strength (Wegovy HD), named as a maximum dosage for weight reduction in adults rather than as a scheduled step — the escalation table itself ends earlier, and whether it applies to anyone in particular is a prescriber question. Because it is a conditional maximum rather than a date on a calendar, the planner's Wegovy ladder ends at 2.4 mg. Wegovy tablets run a separate ladder entirely — 1.5, 4, 9, then 25 mg once daily, escalating every 30 days instead of every 4 weeks — which this planner, built around the weekly injection, doesn't cover.

The table above is the short version. For every approved strength, pen presentation, and maintenance option in one place, see the semaglutide dosage chart and the tirzepatide dosage chart — reference tables rather than a date tool.

Planning around one product? The Ozempic tracker setup, Wegovy tracker setup, Mounjaro tracker setup, and Zepbound tracker setup each walk through the log for that pen. The molecule-level guides to semaglutide tracking and tirzepatide tracking cover pens and vials together.

What this planner doesn't do

It doesn't recommend increasing, holding, or skipping a dose, and it doesn't adjust for missed doses — both are prescribing territory. If your question is about syringe math rather than dates, use the units calculator; if it's about what results to expect at each step, the weight loss calculator maps trial data onto your numbers. And once dates are set, the practical problem becomes remembering them — that's what the GLP-1 shot tracker app is for, alongside knowing what else is worth tracking.

Frequently asked questions

How long do you stay on each GLP-1 dose step?

GLP-1 injection labels for Wegovy, Ozempic, Mounjaro, and Zepbound all set a minimum of 4 weeks per dose step. That minimum is a floor, not a target: prescribers often hold a step longer, and every label allows staying on a lower maintenance dose. Wegovy tablets escalate every 30 days instead and fall outside this planner.

Can this planner tell me when to increase my dose?

No. Increasing a GLP-1 dose is a prescribing decision that depends on tolerability and response, and this planner never makes it. It only converts the label’s minimum intervals into calendar dates, so you can see the earliest date each step could start.

What if my prescriber uses a slower schedule than the label?

Follow the prescriber’s schedule — slower titration is common and allowed by every GLP-1 label. Treat the dates from this planner as the earliest possible boundary, not a plan. The dates that matter are the ones on your prescription, and those are the dates worth putting reminders on.

Do Ozempic and Wegovy use the same titration schedule?

No. Both contain semaglutide, but the Ozempic injection steps through 0.25, 0.5, and optionally 1 and 2 mg, while Wegovy injection climbs five steps — 0.25, 0.5, 1, 1.7, then 2.4 mg maintenance. The products are approved for different indications and their labels set different ladders.

KeepAlong is an independent app and website. Not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.